http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9932098-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54fe5ff6802b61f666533e87ea1f2148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee0e6abd50805b0788c7978ce977643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f02d9b230a6012d62d0d5c87815731
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00
filingDate 1998-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c00b12a588b192312ff92bec62c25b72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50b263b5bb483309f9dd33ff8d6b1b51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18c82a3c4e4aeff6374137955f306c86
publicationDate 1999-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9932098-A3
titleOfInvention Combination of a ramba and a tocopherol
abstract The present invention is concerned with the use of a tocopherol for the manufacture of a medicament for avoiding, alleviating, suppressing or overcoming the adverse side-effects of therapy with a retinoic acid metabolism blocking agent. The present invention is also concerned with the combination of 4-(heteroaryl-methyl)anilines with vitamin E and its use as a medicine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8877162-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9421166-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9439862-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9554993-B2
priorityDate 1997-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395397

Total number of triples: 40.